ICHR Stock Analysis: Ichor Holdings | NASDAQ
Semiconductor Equipment & Materials | NASDAQ, USA | Market Cap: 3.425m USD | 12M Return: 284.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 115M
Qual. Beats: 0
Rev. Trend: 20.4%
Qual. Beats: 4
Warnings
Tailwinds
Seasonality 9.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ichor Holdings, Ltd. (NASDAQ: ICHR) is a US-based supplier that designs, engineers, and manufactures fluid delivery subsystems and components for semiconductor capital equipment. Founded in 1999 and headquartered in Fremont, California, the company operates across Singapore, the United States, Europe, and other international markets, and completed its IPO in December 2016.
The companys core products include gas and chemical delivery subsystems used by semiconductor manufacturers in key process steps such as etch, deposition, chemical-mechanical planarization (CMP), electroplating, and cleaning. It also produces precision-machined components, weldments, brazed assemblies, and surface-treated parts.
Ichor operates as a tier-one subsystem supplier within the semiconductor capital equipment supply chain, selling primarily to wafer fabrication equipment OEMs. This positioning makes the companys revenue tied to the cyclical capital expenditure plans of chipmakers and equipment manufacturers, with demand driven by fab construction, node transitions, and semiconductor industry capacity cycles.
- Semiconductor WFE spending cycle drives fluid delivery subsystem orders
- Gross margin recovery depends on utilization and product mix shift
- Customer concentration with Lam Research and Applied Materials amplifies revenue volatility
| Net Income: -64.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -1.02 > 1.0 |
| NWC/Revenue: 29.79% < 20% (prev 34.85%; Δ -5.07% < -1%) |
| CFO/TA 0.03 > 3% & CFO 24.7m > Net Income -64.1m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (34.6m) vs 12m ago 1.79% < -2% |
| Gross Margin: 9.39% > 18% (prev 12.20%; Δ -2.81% > 0.5%) |
| Asset Turnover: 96.84% > 50% (prev 88.63%; Δ 8.21% > 0%) |
| Interest Coverage Ratio: -8.01 > 6 (EBIT TTM -53.4m / Interest Expense TTM 6.67m) |
| A: 0.29 (Total Current Assets 442.1m - Total Current Liabilities 156.7m) / Total Assets 972.5m |
| B: 0.13 (Retained Earnings 128.6m / Total Assets 972.5m) |
| C: -0.05 (EBIT TTM -53.4m / Avg Total Assets 989.6m) |
| D: 2.19 (Book Value of Equity 668.0m / Total Liabilities 304.5m) |
| Altman-Z'' = 4.30 = AA |
| DSRI: 1.08 (Receivables 93.1m/79.9m, Revenue 958.3m/892.1m) |
| GMI: 1.30 (GM 12.20% / 9.39%) |
| AQI: 1.01 (AQ_t 0.40 / AQ_t-1 0.40) |
| SGI: 1.07 (Revenue 958.3m / 892.1m) |
| TATA: -0.09 (NI -64.1m - CFO 24.7m) / TA 972.5m) |
| Beneish M = -2.63 (Cap -4..+1) = A |
As of July 09, 2026, the stock is trading at USD 88.81 with a total of 1,710,706 shares traded. Over the past week, the price has changed by -20.90%, over one month by +33.05%, over three months by +68.62% and over the past year by +284.79%.
Current recommended Stop Loss: 66.60 (which is 25% or 2.4 ATR below the current price).
Ichor Holdings has received a consensus analysts rating of 4.43. Therefore, it is recommended to buy ICHR.
- StrongBuy: 5
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 81.7 | -8% |
P/E Forward = 71.9424
P/S = 3.5701
P/B = 5.1261
P/EG = 1.0278
Revenue TTM = 958.3m USD
EBIT TTM = -53.4m USD
EBITDA TTM = -21.4m USD
Long Term Debt = 115.8m USD (from longTermDebt, last quarter)
Short Term Debt = 18.5m USD (from shortTermDebt, last quarter)
Debt = 195.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 36.6m
Net Debt = 106.2m USD (calculated: Debt 195.3m - CCE 89.1m)
Enterprise Value = 3.53b USD (3.42b + Debt 195.3m - CCE 89.1m)
Interest Coverage Ratio = -8.01 (Ebit TTM -53.4m / Interest Expense TTM 6.67m)
EV/FCF = 1000.0x (Enterprise Value 3.53b / FCF TTM 137k)
FCF Yield = 0.00% (FCF TTM 137k / Enterprise Value 3.53b)
FCF Margin = 0.01% (FCF TTM 137k / Revenue TTM 958.3m)
Net Margin = -6.69% (Net Income TTM -64.1m / Revenue TTM 958.3m)
Gross Margin = 9.39% ((Revenue TTM 958.3m - Cost of Revenue TTM 868.3m) / Revenue TTM)
Gross Margin QoQ = 11.63% (prev 9.38%)
Tobins Q-Ratio = 3.63 (Enterprise Value 3.53b / Total Assets 972.5m)
Interest Expense / Debt = 3.42% (Interest Expense 6.67m / Debt 195.3m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -42.2m (EBIT -53.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.82 (Total Current Assets 442.1m / Total Current Liabilities 156.7m)
Debt / Equity = 0.29 (Debt 195.3m / totalStockholderEquity, last quarter 668.0m)
Debt / EBITDA = -4.96 (negative EBITDA) (Net Debt 106.2m / EBITDA -21.4m)
Debt / FCF = 775.2 (Net Debt 106.2m / FCF TTM 137k)
Total Stockholder Equity = 671.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -6.48% (Net Income -64.1m / Total Assets 972.5m)
RoE = -9.56% (Net Income TTM -64.1m / Total Stockholder Equity 671.1m)
RoCE = -6.79% (EBIT -53.4m / Capital Employed (Equity 671.1m + L.T.Debt 115.8m))
RoIC = -5.37% (negative operating profit) (NOPAT -42.2m / Invested Capital 786.4m)
WACC = 16.48% (E(3.42b)/V(3.62b) * Re(17.27%) + D(195.3m)/V(3.62b) * Rd(3.42%) * (1-Tc(0.21)))
Discount Rate = 17.27% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 98.88 | Cagr: 7.51%
[DCF] Terminal Value 48.97% ; FCFF base≈4.25m ; Y1≈3.73m ; Y5≈3.01m
[DCF] Fair Price = N/A (negative equity: EV 21.0m - Net Debt 106.2m = -85.2m; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.23 | # QB: 0
Revenue Correlation: 20.45 | Revenue CAGR: 2.11% | SUE: 1.70 | # QB: 4
EPS current Quarter (2026-06-30): EPS=0.31 | Chg30d=+0.00% | Revisions=+67% | Analysts=7
EPS next Quarter (2026-09-30): EPS=0.41 | Chg30d=+0.00% | Revisions=+44% | Analysts=7
EPS current Year (2026-12-31): EPS=1.38 | Chg30d=+0.00% | Revisions=+62% | GrowthEPS=+499.4% | GrowthRev=+26.4%
EPS next Year (2027-12-31): EPS=2.70 | Chg30d=+0.00% | Revisions=+62% | GrowthEPS=+95.8% | GrowthRev=+20.3%
[Analyst] Revisions Ratio: +80% (up=21, down=1)